Phase I and Pharmacokinetics Study to Determine the Safety of BIBX 1382 in Patients With a Solid Tumor on a Continuous Daily Oral Administration Schedule and After Single Oral and Intravenous Doses.
Phase of Trial: Phase I
Latest Information Update: 10 Jul 2012
At a glance
- Drugs BIBX 1382 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 10 Jul 2012 Additional trial location (USA) added as reported by ClinicalTrials.gov.
- 10 Jul 2012 Status changed from active, no longer recruiting to suspended as reported by ClinicalTrials.gov.
- 23 Jul 2008 Planned patient number is now 80 as reported by ClinicalTrials.gov.